SMC announced that Dr. Falk Pharma GmbH presented results of a study using STAM™ model at poster presentation at AASLD The Liver Meeting® 2019 in Boston, MA, November 8-12, 2019.

Title: “Norursodeoxycholic acid (norUDCA) significantly ameliorates liver injury in the STAM mouse model for non-alcoholic steatohepatitis (NASH)”